Label: STERILE WATER- water injection, solution
- NDC Code(s): 0990-7118-07
- Packager: ICU Medical Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: New Drug Application
Updated June 19, 2020
If you are a consumer or patient please visit this version.
- BOXED WARNING (What is this?)
- SPL UNCLASSIFIED SECTION
Sterile Water for Injection, USP is a sterile, nonpyrogenic water for injection intended only for dilution purposes. The pH is 5.4 (5.0 to 7.0). The Pharmacy Bulk Package is a sterile dosage form which contains multiple single doses for use only in a pharmacy bulk admixture program.
Sterile Water for Injection, USP contains no bacteriostat, antimicrobial agent or added buffer.
Sterile Water for Injection, USP may be classified as a sterile diluent and pharmaceutical vehicle.
Sterile Water for Injection, USP is chemically designated H2O.
The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions inside the plastic container also can leach out certain of its chemical components in very small amounts before the expiration period is attained. However, the safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers.
Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).
Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.
- INDICATIONS AND USAGE
FOR DILUTION ONLY.
Do not heat over 66°C (150°F).
This preparation is solute-free and its entry into the circulation undiluted will cause hemolysis.
Absorption of large amounts of Sterile Water for Injection, USP with additives can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.
WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum.
Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.
- ADVERSE REACTIONS
DOSAGE AND ADMINISTRATION
Sterile Water for Injection, USP in the 2000 mL flexible Pharmacy Bulk Package is designed for use with automated compounding devices for preparing intravenous admixtures. Dosages will be in accordance with the recommendation of the prescribing physician.
Sterile Water for Injection, USP is not intended for direct infusion. Admixtures should be made by or under the direction of a pharmacist using strict aseptic technique under a laminar flow hood. Compounded admixtures may be stored under refrigeration for up to 24 hours. Administration of admixtures should be completed within 24 hours after removal from refrigeration.
The Pharmacy Bulk Package is intended only for use in the preparation of sterile, intravenous admixtures using automated compounding devices.
Additives may be incompatible with the fluid withdrawn from this container. Consult with pharmacist, if available. When compounding admixtures, use aseptic technique, mix thoroughly and do not store.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits. See PRECAUTIONS.
Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
Recommended Directions for Use of the Pharmacy Bulk Package
Use Aseptic Technique
1. During use, container must be stored, and all manipulations performed, in an appropriate laminar flow hood.
2. Remove cover from outlet port at bottom of container.
3. Insert piercing pin of transfer set and suspend unit in a laminar flow hood. Insertion of a piercing pin into the outlet port should be performed only once in a Pharmacy Bulk Package solution. Once the outlet site has been entered, the withdrawal of container contents should be completed promptly in one continuous operation. Should this not be possible, a maximum time of 4 hours from transfer set pin or implement insertion is permitted to complete fluid transfer operations; i.e., discard container no later than 4 hours after initial closure puncture.
4. Sequentially dispense aliquots of Sterile Water for Injection, USP into I.V. containers using appropriate transfer set. During fluid transfer operations, the Pharmacy Bulk Package should be maintained under the storage conditions recommended in the labeling.
Sterile Water for Injection, USP is supplied in 2000 mL flexible Pharmacy Bulk Packages.
NDC No. Product Container Size (mL) 0409-7118-07 Sterile Water for Injection, USP 2000 0990-7118-07 Sterile Water for Injection, USP 2000
ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both codes are expected to be in the market for a period of time.
Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing.
Revised: July, 2018
ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
PRINCIPAL DISPLAY PANEL - 2000 mL Bag Label
FOR INJECTION, USP
PHARMACY BULK PACKAGE — Not For Direct Infusion.
FOR USE ONLY WITH AUTOMATED COMPOUNDING DEVICES.
pH 5.4 (5.0 TO 7.0).
INDICATIONS: FOR PREPARATION OF
INTRAVENOUS ADMIXTURES USING AUTOMATED
CONTRAINDICATIONS: NOT FOR DIRECT
INFUSION. DO NOT USE FOR NON-AUTOMATED
ADMIXTURE PREPARATIONS. USE ONLY IF
SOLUTION IS CLEAR AND CONTAINER IS
WARNINGS: NOT ISOTONIC. HEMOLYTIC. DO NOT
HEAT OVER 66°C (150°F). CONTAINS NO
BACTERIOSTAT. DISCARD UNUSED PORTION. USE
DOSAGE AND ADMINISTRATION: AS DIRECTED BY
PHYSICIAN. SEE INSERT FOR COMPLETE
TIME OF ENTRY:___________________________
CAUTION: USE ONLY IN LAMINAR FLOW HOOD.
ONCE THE OUTLET SITE HAS BEEN ENTERED, THE
WITHDRAWAL OF CONTAINER CONTENTS
SHOULD BE PROMPTLY COMPLETED IN ONE
CONTINUOUS OPERATION. DISCARD CONTAINER
NOT LATER THAN 4 HOURS AFTER INITIAL
CLOSURE PUNCTURE. SEE INSERT.
CONTAINS NO MORE THAN 25 mcg/L OF
ICU Medical, Inc., Lake Forest, Illinois, 60045, USA
PRINCIPAL DISPLAY PANEL - 2000 mL Bag Overwrap
TO OPEN TEAR AT NOTCH
DO NOT REMOVE FROM OVERWRAP UNTIL READY FOR USE. AFTER REMOVING
THE OVERWRAP, CHECK FOR MINUTE LEAKS BY SQUEEZING CONTAINER FIRMLY.
IF LEAKS ARE FOUND, DISCARD SOLUTION AS STERILITY MAY BE IMPAIRED.
RECOMMENDED STORAGE: ROOM TEMPERATURE (25°C). AVOID EXCESSIVE
HEAT. PROTECT FROM FREEZING. SEE INSERT.
INGREDIENTS AND APPEARANCE
water injection, solution
Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0990-7118 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER 1 mL in 1 mL Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0990-7118-07 6 in 1 CASE 06/01/2019 1 2000 mL in 1 BAG; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA019869 06/01/2019 Labeler - ICU Medical Inc. (118380146)